TY  - JOUR
TI  - Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence 
and Perinatal Outcomes in Pregnant Women
AB  - Objectives: Vertical transmission of hepatitis B virus, hepatitis 
C virus, (HBV, HCV) and human immunodeficiency viruses (HIV) 
infections is an important public health problem. The aim of this 
study was to determine the rates of hepatitis B, anti-HCV and antiHIV seropositivities in pregnant women in a city and to evaluate the 
infections in terms of perinatal outcomes.
Materials and Methods: In this retrospective study, 8,464 patients 
who gave birth in obstetrics and gynecology clinic were recorded. 
Seropositivity rates of pregnant women were investigated according 
to the results of hepatitis B surface antigen (HBsAg), HCV antibody 
and anti-HIV antibody. The rates were determined according to 
years and perinatal results and statistical comparison was made.
Results: HBsAg seropositivity in pregnant women included in the 
study was 2.8 % (n=55) in 2015, 2.2% (n=52) in 2016, 2.3% (n=47) 
in 2017 and 2.2% (n=49) in 2018. The 4 year average was found 
to be 2.3% (n=203). There was no significant difference between 
the years (p>0.05). Among all our patients, 4-year mean anti-HCV 
seropositivity was 0.57% (n=49) and there was no difference 
between years (p>0.05). Anti-HIV seropositivity was found to 
be 0.09% on average, and there was no statistically significant 
difference over the years (p>0.05).
Conclusion: Since hepatitis B, which is a preventable viral disease, 
has a risk of transmission during delivery and if it is transmitted to the 
fetus, it may lead to fatal complications at later ages, it is necessary 
to screen all pregnant women in terms of HBsAg seropositivity and 
to include it in an antepartum planning program to protect and treat 
newborns from infection. Although the transmission rate of HCV is 
low in the society, considering its clinical course, screening of HCV together with HIV in risky groups and pregnant women antibody 
positivity is considered important for the health of the society and 
newborns.
AU  - Çeleğen, İzzet
AU  - uçkan, Taner
AU  - uckan, Kazım
DO  - 10.4274/vhd.galenos.2021.2020-12-2
PY  - 2021
JO  - Viral Hepatitis Journal
VL  - 27
IS  - 2
SN  - 2147-2939
SP  - 103
EP  - 108
DB  - TRDizin
UR  - http://search/yayin/detay/514126
ER  -